Skip to main content
CELLULAR GOODS PLC logo

CELLULAR GOODS PLC — Investor Relations & Filings

Ticker · CBX ISIN · GB00BK964W87 LEI · 213800IXPX4Z2MKX2U28 IL Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2022-02-21 Regulatory Filings
Country GB United Kingdom
Listing IL CBX

About CELLULAR GOODS PLC

https://cellular-goods.com/

Cellular Goods PLC is a wellness company focused on developing consumer products using lab-grown, biosynthetic cannabinoids. The company's initial product lines included high-end skincare and topical athletic recovery solutions, utilizing cannabinoids like Cannabidiol (CBD) produced via cellular agriculture. This method aims to provide high-purity and sustainable ingredients. In early 2024, the company announced a strategic shift to focus on artificial intelligence applications within the beauty sector, leading to a proposed name change to Cel AI PLC.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short announcement related to trading mechanics rather than a comprehensive financial report or a standard corporate action like a dividend or director dealing. Given the nature of the announcement (a brief update on trading procedures disseminated via the RNS system) and its brevity (1919 chars), it fits best under the general regulatory announcement category, which is RNS, as it doesn't align with the more specific categories like ER, DIV, or DIRS.
2022-02-21 English
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement regarding trading halts/extensions. This type of general regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing category, RNS (Regulatory Filings). The document length is short (1936 chars), supporting the idea that it is an announcement rather than a full report.
2022-02-21 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short announcement related to trading mechanics rather than a comprehensive financial report (like 10-K or IR) or a management change. Given its nature as a brief, regulatory-style announcement disseminated via the RNS system, and lacking a more specific category like DIV, DIRS, or ER, the most appropriate classification is the general regulatory announcement fallback category.
2022-02-21 English
Strategy and trading update
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and contains information deemed 'inside information' under Market Abuse Regulation, which is characteristic of regulatory news service announcements. The content includes a 'Strategy and trading update,' details on a 'Product launch on Amazon Marketplace,' and a 'Board change' (CEO stepping down). This combination of operational updates, strategic review, and management changes, released via RNS, suggests it is a general regulatory announcement rather than a specific periodic report (like 10-K or IR) or a dedicated management discussion (MDA). Since it is a broad update released through the official news service (RNS), the most appropriate classification is Regulatory Filings (RNS), as it serves as the general category for such announcements not covered by more specific codes like ER or MANG, although it contains elements of MANG and MDA. Given the context of being an RNS release detailing multiple business updates, RNS is the best fit.
2022-02-21 English
White paper on cannabinoids and skin aging
Regulatory Filings Classification · 99% confidence The document is identified by the RNS Number (4394A) and the header 'RNS Number'. It is explicitly labeled as a 'Press release' and distributed via 'Reach, the non-regulatory press release distribution service of RNS'. The content announces the release of a 'major new white paper' and provides details about its findings and availability. Since this is an announcement about the publication of research/information rather than the full regulatory report itself (like 10-K or IR), and it is distributed via a press release service (Reach/RNS), it fits best under the general Regulatory Filings (RNS) category, as it is a non-regulatory announcement disseminated through the RNS system. It is not a specific financial report, earnings release, or management discussion.
2022-02-02 English
Group of companies' accounts made up to 2021-08-31
Regulatory Filings
2022-01-20 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.